Blog

Partnering with Advarra, one nonprofit successfully obtained an Emergency Use Authorization from the FDA within five weeks.

Emergency preparedness plans help institutions plan, prepare for, and respond to emergencies as they arise.

Explore the benefits of switching from paper to eSource, tips for implementation, and how to maintain compliance.

There is an increasing challenge to find eligible patients and build trial awareness, so how should the industry address them?

An Advarra expert provides insight in this Q&A session on the FDA inspection readiness process, including how to improve current workflows.

In this blog, we take a look at popular blog posts and webinars in 2021 garnering the most interest from research community members like you.

Advarra experts Joan Versaggi and Leslie Paul answer questions from the webinar- FDA Updates: BIMO – What Sponsors Need to Know.

Rosamund Round VP of Parexel’s Patient Innovation Center and DCTs shares key strategies for increasing diversity in decentralized trials.

An essential step in research, Phase I oncology studies raise unique ethical challenges for sponsors, investigators, and IRBs.

An Advarra Trend Report found sites and sponsors alike are facing shifts as they continue to navigate the pandemic.

Maintaining an effective partnership with your technology vendor is key to implementation success.

Clinical Research Workforce survey finds sites once had similar habits, but everyone is approaching the "next normal" differently.